Caladrius Biosciences, Inc. (Caladrius)

Oncology Corporate Profile

HQ Location

420 Lexington Avenue, Suite 350
New York, NY 10170

Company Description

Caladrius Biosciences, Inc. is among the first of a new breed of immunotherapy companies with proven expertise and unique experience in cell process optimization, development, and manufacturing. Caladrius is a cell therapy leader with late-stage clinical programs based on a proprietary platform technology for immuno-oncology, as well as additional platform technologies for ischemic repair and immunomodulation, and capabilities that support other cell therapy developers. This integrated approach supports the industry in bringing significant life-improving medical treatments to market.

Website: http://www.caladrius.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
CLB20immunotherapyMelanomaIII

View additional information on product candidates here »

Pipeline image

Source


http://www.caladrius.com

Recent News Headlines

There are no news items to display